BR PHARM CO., Ltd. of Wonju-Si, Gangwondo at MEDICA 2020 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

BR PHARM CO., Ltd.

13, Sinpyeong-Ro, Jijeong-Myeon Wonju-Si, Gangwon-do, 26348 Wonju-Si, Gangwondo
Korea, Republic
Telephone +82 33 9014500
Fax +82 33 9014600
brpharm6@brpharm.com

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Contact

Liam YUN

Dep. General Manager

Phone
+82-2-2148-6778
+82-10-3662-5111 (Mobile, whatsapp)

Email
brpharm3@brpharm.com

Visit us

Unsettled / NN

19.11.2020

Topic

all-day

Polynucleotid Intra-articular injection - HP CELL VITARAN J

HP Cell VITARAN J is PN(Polynucleotide) intra-articular injection for osteoarthritis.

  • HP Cell VITARAN J is a biomaterial for tissue restoration using Polynucleotide(PN) and can be treated for the purpose of reducing mechanical friction between articular cartilage of synovial(joint). 
  • It is injected into the synovial(joint) cavity and reduces mechanical friction of the joint by maintaining its volume and shape for a certain period. HP Cell VITARAN J also relieves pain with its anti-inflammation effect.
  • CE Certified 

More Less

Our range of products

Product categories

  • 04  Physiotherapy / orthopaedic technology
  • 04.17  Other equipment and devices for physiotherapy and orthopaedy

Our products

Product category: Other equipment and devices for physiotherapy and orthopaedy

HP Cell VITARAN J - intra-articular injection

HP Cell VITARAN J is PN(Polynucleotide) intra-articular injection for osteoarthritis.

HP Cell VITARAN J is a biomaterial for tissue restoration using Polynucleotide(PN) and can be treated for the purpose of reducing mechanical friction between articular cartilage of synovial(joint). 
It is injected into the synovial(joint) cavity and reduces mechanical friction of the joint by maintaining its volume and shape for a certain period. HP Cell VITARAN J also relieves pain with its anti-inflammation effect.
CE Certification – CE2265, Medical Device Class III, No. 2020-MDD/QS-068

  • Ingredient : Sodium Polynucleotide 20mg/ml
  • Classification : Medical Device (Class III) 
  • Efficacy ∙ Purpose of use : Reducing mechanical friction between articular cartilage of synovial joint and and physical restoration by injection intra-articular injection
  • Packaging Unit : 2ml prefilled syringe/box
  • Manufacturer : BR PHARM CO., Ltd. (South Korea)

More Less

Product category: Other equipment and devices for physiotherapy and orthopaedy

Revitrane Dermal Filler

Revitrane – Maximized advantage of HA filler

Safe monophasic type filler with minimal crosslinking agent(BDDE).
  • Safety :  High-quality raw material,  Advanced residual BDDE cleaning process
  • Excellent Viscoelasticity : Uniform cross-linked HA structure, Soft viscoelastic gel texture for making natural volume
  • Cohesivity : Keep initial volume for long time by cohesive gel, Improved skin integration that blends with surrounding skin tissue
  • Soft Injection : Smooth and uniform injection

More Less

Product category: Other equipment and devices for physiotherapy and orthopaedy

HP Cell VITARAN Skin Healer - Polynucleotide mesotherapy

Skin rejuvenation solution made from BR PHARM’s unique PDRN

  • Product Name : HP Cell VITARAN Skin Healer I 
  • Ingredient : Polynucleotide 20mg/ml (2%)
  • Efficacy : Skin rejuvenation (full face)
                       Rejuvenate scars (depressed and sunken scars)
                       Improvement of skin elasticity and restore skin thickness
  • Packaging Unit : 1ml syringe x2/box


  • PDRN is a biological (fish) -derived raw material, it is important to ensure the safety of the raw material and uniform quality control.
  • "PDRN activates the Adenosine A2A receptor, which activates tissue regeneration mechanisms in the body, and promotes wound healing through its anti-inflammation effects."

More Less

About us

Company details

Bio-pharmaceutical company with expertise of regenerative medicine

BR Pharm performs research activities of wide scope of regenerative medicine technologies for the purpose of ensuring comfort and pleasant lives based on core technologies by making use of PDRN.

BR Pharm owns manufacture technology of cell cycling activator of PDRN medicine for producing regenerative medicine, and listed raw material medicine (PDRN) on DMF, and is certified of BGMP (Bulk Good Manufacture Practice) by the Ministry of Food and Drug Safety. Further, BR Pharm cooperates governmental institutes for consumption and supply of safe PDRN raw material medicine.

More Less

Company data

Sales volume

50-99 Mio US $

Export content

max. 75%

Number of employees

50-99

Foundation

2005

Area of business
  • Electromedical equipment / Medical Technology
  • Physiotherapy / Orthopaedic Technology

Company information as a PDF file